DEARhealth

DEARhealth is a Dutch-American healthcare spin-out from the University of California, Los Angeles (UCLA), founded in 2013 by gastroenterologists Daniel Hommes and Eric Esrailian.

DEARhealth
Private
IndustryHealthcare
FoundedLos Angeles, California, United States (2013)[1]
FounderDaniel Hommes
Eric Esrailian[2]
Headquarters
Los Angeles, California; Amsterdam
,
United States, The Netherlands
Key people
Daniel Hommes (co-Founder and CEO), Alberto Montilla (CTO), Aria Zand (CPO), Reender Beks (CFO), Katinka de Korte (General Manager Europe)
Websitedearhealth.com

The company develops artificial intelligence-powered, personalized care pathways for chronic care.[3] The platform supports Value Based Health Care and aims to get the best outcomes for patients and providers, optimizing a value quotient (vQ), defined as patient value/provider costs.[4] Treatment areas include inflammatory bowel disease, pain management, liver diseases, ovarian cancer, chronic kidney diseases, low back pain and epilepsy.[5]

History

In 2012 DEARhealth started as a research project at UCLA. In 2013 DEARhealth was founded as a company. In June 2019 DEARhealth announced collaboration outside UCLA with UCB on epilepsy.[6] In July 2019, the company closed a series A funding round led by Philips.[7]

gollark: Also whatever Apple is doing.
gollark: Yes, the Cortex-X2 and such are apparently very competitive.
gollark: Supercomputers are mostly good through parallelism. It's generally the case that ARM devices you can actually get are worse in single core performance than x86 ones you can actually get.
gollark: All questions or statements with "metaverse" in them can immediately be discarded safely.
gollark: I'm pretty sure that's linear regression.

References
  1. "Bloomberg listing". Bloomberg.
  2. "Crunchbase listing". TechCrunch.
  3. "Philips leads $6.8M funding round for AI-driven health tech startup". www.beckershospitalreview.com. Retrieved 2019-07-24.
  4. Esrailian, Eric; Hommes, Daniel W. (2015-03-01). "How Does a Gastroenterologist Show Value?". Clinical Gastroenterology and Hepatology. 13 (3): 616–617. doi:10.1016/j.cgh.2014.10.024. ISSN 1542-3565. PMID 25445770.
  5. "Philips, Vesalius Biocapital III, Health Innovations invest in DEARhealth, AI health tech start-up". dearhealth.com. Retrieved 2019-07-24.
  6. "UCB and Dearhealth Partner to Improve Care Coordination for Patients with Epilepsy". Healthcare Analytic News. Retrieved 2019-07-24.
  7. "Philips, Vesalius Biocapital III, Health Innovations invest in DEARhealth, AI health tech start-up". MarketWatch. Retrieved 2019-07-24.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.